Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering ...
A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer's disease.
A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor ...
In recognition of Alzheimer's Awareness Month this November, the Alzheimer's Drug Discovery Foundation (ADDF) is taking bold steps forward in the fight against Alzheimer's disease. The ADDF proudly ...
In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...
Novo Nordisk is expected to announce soon whether its blockbuster GLP-1 drug semaglutide can help slow Alzheimer’s disease ...
Novo Nordisk will soon announce the results of perhaps the most ambitious studies yet of its GLP-1 drug: whether it can help ...
A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...
Stocktwits on MSN
Anavex Retail Traders See Silver Lining In EMA Committee Postpones Alzheimer’s Drug Verdict: Delay 'Actually A Positive Sign'
The CHMP issued a negative trend vote but postponed its final decision to December. ・Retail traders were divided, citing ...
Alzheimer’s drug donanemab approved for use by drug regulator, likely to be available in India next year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback